# Tiziana Life Sciences (stock symbol: TLSA) Logo in transparent PNG and SVG formats

## Tiziana Life Sciences Logo large

### Tiziana Life Sciences Logo large Download PNG (75.83 KB)

![Tiziana Life Sciences Logo large Download PNG (75.83 KB)](/img/orig/TLSA_BIG-76fe01e2.png)

### Tiziana Life Sciences Logo large Download SVG (17.86 KB)

![Tiziana Life Sciences Logo large Download SVG (17.86 KB)](/img/orig/TLSA_BIG-f3ba029c.svg)

## Tiziana Life Sciences Logo icon format

### Tiziana Life Sciences Logo icon format Download PNG (312.19 KB)

![Tiziana Life Sciences Logo icon format Download PNG (312.19 KB)](/img/orig/TLSA-a78495ea.png)

### Tiziana Life Sciences Logo icon format Download SVG (2.73 KB)

![Tiziana Life Sciences Logo icon format Download SVG (2.73 KB)](/img/orig/TLSA-9aa8f870.svg)

## Tiziana Life Sciences Logo large for dark backgrounds

### Tiziana Life Sciences Logo large for dark backgrounds Download PNG (430.13 KB)

![Tiziana Life Sciences Logo large for dark backgrounds Download PNG (430.13 KB)](/img/orig/TLSA_BIG.D-dab09afc.png)

### Tiziana Life Sciences Logo large for dark backgrounds Download SVG (17.85 KB)

![Tiziana Life Sciences Logo large for dark backgrounds Download SVG (17.85 KB)](/img/orig/TLSA_BIG.D-88c41ad1.svg)

## About Tiziana Life Sciences

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. The company was incorporated in 1998 and is headquatered in London, the United Kingdom.

1. Website domain: tizianalifesciences.com
2. Employees: 14
3. Marketcap: $80.29 Million USD


## Categories
- [x] ðŸ‡¬ðŸ‡§ United Kingdom
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
